ChemicalBook > CAS DataBase List > 3(2H)-Pyridazinone, 4-chloro-5-[4-[4-fluoro-2-(trifluoromethyl)phenoxy]-5,8-dihydropyrido[3,4-d]pyrimidin-7(6H)-yl]-

3(2H)-Pyridazinone, 4-chloro-5-[4-[4-fluoro-2-(trifluoromethyl)phenoxy]-5,8-dihydropyrido[3,4-d]pyrimidin-7(6H)-yl]-

Product Name
3(2H)-Pyridazinone, 4-chloro-5-[4-[4-fluoro-2-(trifluoromethyl)phenoxy]-5,8-dihydropyrido[3,4-d]pyrimidin-7(6H)-yl]-
CAS No.
2413739-88-3
Chemical Name
3(2H)-Pyridazinone, 4-chloro-5-[4-[4-fluoro-2-(trifluoromethyl)phenoxy]-5,8-dihydropyrido[3,4-d]pyrimidin-7(6H)-yl]-
Synonyms
Evifacotrep;Evifacotrep, 10 mM in DMSO;Evifacotrep,inhibit,Inhibitor,TRP Channel,Transient receptor potential channels;5-chloro-4-[4-[4-fluoro-2-(trifluoromethyl)phenoxy]-6,8-dihydro-5H-pyrido[3,4-d]pyrimidin-7-yl]-1H-p;5-chloro-4-[4-[4-fluoro-2-(trifluoromethyl)phenoxy]-6,8-dihydro-5H-pyrido[3,4-d]pyrimidin-7-yl]-1H-pyridazin-6-one;3(2H)-Pyridazinone, 4-chloro-5-[4-[4-fluoro-2-(trifluoromethyl)phenoxy]-5,8-dihydropyrido[3,4-d]pyrimidin-7(6H)-yl]-;4-chloro-5-{4-[4-fluoro-2-(trifluoromethyl)phenoxy]-5H,6H,7H,8H-pyrido[3,4-d]pyrimidin-7-yl}-2,3-dihydropyridazin-3-one
CBNumber
CB09766563
Molecular Formula
C18H12ClF4N5O2
Formula Weight
441.77
MOL File
2413739-88-3.mol
More
Less

3(2H)-Pyridazinone, 4-chloro-5-[4-[4-fluoro-2-(trifluoromethyl)phenoxy]-5,8-dihydropyrido[3,4-d]pyrimidin-7(6H)-yl]- Property

Density 
1?+-.0.1 g/cm3(Predicted)
storage temp. 
Store at -20°C
solubility 
DMSO : 50 mg/mL (113.18 mM; ultrasonic and warming and heat to 60°C)
form 
Solid
pka
9.10±0.60(Predicted)
color 
White to off-white
More
Less

Hazard and Precautionary Statements (GHS)

More
Less

3(2H)-Pyridazinone, 4-chloro-5-[4-[4-fluoro-2-(trifluoromethyl)phenoxy]-5,8-dihydropyrido[3,4-d]pyrimidin-7(6H)-yl]- Chemical Properties,Usage,Production

Uses

Evifacotrep, a short transient receptor potential channel 5 and 4 (TRPC5/TRPC4) antagonist (WO2020061162, compound 100), can be used for the research of neurological diseases. Evifacotrep targets to TRPC5/TRPC4 with IC50s ≤50 nM[1].

in vivo

Evifacotrep (30 mg/kg; sc; once daily or twice daily for 10 days) results in reduced urinary albumin excretion on following injury with puromycinaminonucleoside (PAN)[1].

References

[1] WO2020061162

3(2H)-Pyridazinone, 4-chloro-5-[4-[4-fluoro-2-(trifluoromethyl)phenoxy]-5,8-dihydropyrido[3,4-d]pyrimidin-7(6H)-yl]- Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

3(2H)-Pyridazinone, 4-chloro-5-[4-[4-fluoro-2-(trifluoromethyl)phenoxy]-5,8-dihydropyrido[3,4-d]pyrimidin-7(6H)-yl]- Suppliers

TargetMol Chemicals Inc.
Tel
+1-781-999-5354; +17819995354
Email
marketing@targetmol.com
Country
United States
ProdList
32435
Advantage
58
Aladdin Scientific
Tel
Email
tp@aladdinsci.com
Country
United States
ProdList
52923
Advantage
58
TargetMol Chemicals Inc.
Tel
+1-781-999-5354;
Email
support@targetmol.com
Country
United States
ProdList
39035
Advantage
58

2413739-88-3, 3(2H)-Pyridazinone, 4-chloro-5-[4-[4-fluoro-2-(trifluoromethyl)phenoxy]-5,8-dihydropyrido[3,4-d]pyrimidin-7(6H)-yl]-Related Search:


  • 3(2H)-Pyridazinone, 4-chloro-5-[4-[4-fluoro-2-(trifluoromethyl)phenoxy]-5,8-dihydropyrido[3,4-d]pyrimidin-7(6H)-yl]-
  • 5-chloro-4-[4-[4-fluoro-2-(trifluoromethyl)phenoxy]-6,8-dihydro-5H-pyrido[3,4-d]pyrimidin-7-yl]-1H-pyridazin-6-one
  • Evifacotrep
  • Evifacotrep,inhibit,Inhibitor,TRP Channel,Transient receptor potential channels
  • 5-chloro-4-[4-[4-fluoro-2-(trifluoromethyl)phenoxy]-6,8-dihydro-5H-pyrido[3,4-d]pyrimidin-7-yl]-1H-p
  • 4-chloro-5-{4-[4-fluoro-2-(trifluoromethyl)phenoxy]-5H,6H,7H,8H-pyrido[3,4-d]pyrimidin-7-yl}-2,3-dihydropyridazin-3-one
  • Evifacotrep, 10 mM in DMSO
  • 2413739-88-3
  • C18H12ClF4N5O2